| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | Dec 14, 2024 | Chakma Justin Chief Business Officer | Sell | Ars Pharmaceuticals, Inc. | SPRY | $12.23 | $2M | -51.46% |
| Dec 10, 2024 | Dec 12, 2024 | Chakma Justin Chief Business Officer | Sell | Ars Pharmaceuticals, Inc. | SPRY | $13.15 | $657,625 | -26.83% |
| Dec 04, 2024 | Dec 07, 2024 | Chakma Justin Chief Business Officer | Sell | Ars Pharmaceuticals, Inc. | SPRY | $14.11 | $2M | -51.47% |
| Dec 02, 2024 | Dec 05, 2024 | Chakma Justin Chief Business Officer | Sell | Ars Pharmaceuticals, Inc. | SPRY | $13.43 | $1M | -39.76% |
| Nov 25, 2024 | Nov 27, 2024 | Chakma Justin Chief Business Officer | Sell | Ars Pharmaceuticals, Inc. | SPRY | $14.12 | $1M | -42.30% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.